(Q43885591)

English

Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

Gerhard Ehninger

8

object named as

Ehninger G

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Naumann R

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Vaic A

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Beuthien-Baumann B

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bredow J

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kropp J

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kittner T

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Franke WG

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

793-800

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Ga-67 SPECT before and after treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Residual mass in aggressive lymphoma--does size, measured by computed tomography, influence clinical outcome?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03147.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.03147.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43885591&oldid=2104152529"